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Abstract
Background: Capacity for health economics analysis and research is indispensable for evidence-informed
allocations of scarce health resources; however, little is known about the experience and capacity strengthening
preferences of academics and practitioners in the Eastern Mediterranean region. This study aimed to assess the
needs for strengthening health economics capacity in Jordan, Lebanon, the occupied Palestinian territories and
Turkey as part of the Research for Health in Conflict in the Middle East and North Africa (R4HC) project.
Methods: We combined a bibliometric analysis of health economics outputs based on a literature search conducted
across seven databases with an online survey of academic researchers and non-academic practitioners. The records
included in the bibliometric analysis were original studies and reviews with an explicit economic outcome related to
health, disease or disability, had at least one author in Jordan, Lebanon, Palestine or Turkey, and were published
between January 2014 and December 2018. Two types of analyses were conducted using VOSviewer software, namely
keyword co-occurrence and co-publication networks across countries and organisations. The online survey asked
academic researchers, analysts and decision-makers – identified through the bibliometric analysis and regional
professional networks – about previous exposure to and priorities for capacity development in health economics.
Results: Of 15,185 records returned by the literature search, 566 were included in the bibliometric analysis. Organisations in
Turkey contributed more than 80% of records and had the broadest and most diverse network of collaborators, nationally
and internationally. Only 1% (n= 7) of studies were collaborations between researchers in two or more different jurisdictions.
Cost analysis, cost-effectiveness analysis and health system economics were the main health economics topics across the
included studies. Economic evaluations, measuring the economic burden of disease and health equity, were reported by
survey respondents (n= 80) as the most important areas to develop in. Short courses, learn-by-doing and mentoring from
an experienced professional were, in aggregate, the most preferred learning styles.
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Conclusions: Existing pockets of health economic expertise in the region can constitute the base of future capacity
development efforts. Building confidence toward applying specific methods and trust toward stimulating cross-jurisdiction
collaborations appear essential components for sustainably developing health economics capacity.
Keywords: health economics, capacity strengthening, Eastern Mediterranean, Middle East and North Africa, online survey,
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Background
Achieving and maintaining Universal Health Coverage
(UHC), whereby everyone has access to health services of
adequate quality when they need them and without risk of
going into poverty, depends on health systems and health
decision-makers making fair, evidence-informed decisions
about how to prioritise the spending of limited available
resources [1]. The capacity to conduct health economics
research and analyses is indispensable to achieve this end
– where capacity for research can be defined as “enhan-
cing the abilities of individuals, organisations and systems
to undertake and disseminate high quality research effi-
ciently and effectively” [2]. The need for such capacity
could not be more relevant for health systems in the
Eastern Mediterranean region, whose decision-makers are
facing difficult choices in allocating scarce resources in
the face of severe and context-specific constraints (e.g.
conflict, political instability, stagnant economic growth) at
the same time as embarking on reforms towards UHC [3].
However, the broader constraints in funding, understand-
ing and capacity for health research ecosystems in the re-
gion have now been well documented [4, 5].
A foundational step in designing capacity development
programmes is to conduct a needs assessment, understood
as “the systematic study of a problem or innovation, incorp-
orating data and opinions from varied sources, in order to
make effective decisions or recommendations about what
should happen next” [6]. Available reviews of the health
economic literature conducted in the region, be they with a
cross-country [7, 8] or single-country focus [9, 10], all sug-
gest a limited use of economic evaluation and substantial
scope for improving methodological quality. There are also
indications that most pharmacy schools offer pharmacoeco-
nomics courses as part of their curriculum, albeit with
widely varying hours and topics [11]. However, there are
many more areas of health economics other than pharma-
coeconomics and economic evaluation, such as health
equity or measuring the performance of service providers
and health systems, both providing crucial insights in the
context of reforms towards UHC. Very little is known
about the capacity specific to these areas of health econom-
ics or capacity development modalities. We identified only
one comprehensive needs assessment for health economics
in the region, focusing on the professional development
needs of junior public health professionals in Turkey [12].
In that study, health economics was the professional area
(versus health policy, environmental health, medical an-
thropology and epidemiology) with the largest reported gap
between perceived importance and self-assessed perform-
ance – particularly ‘statistical and econometric analysis’,
‘microeconomics of healthcare’ and ‘health accounting’.
We report the findings of a needs assessment for
health economics research and practice in four Eastern
Mediterranean jurisdictions – Jordan, Lebanon, the oc-
cupied Palestinian territories (OPT) and Turkey. The
study was conducted as a preparatory step for develop-
ing a programme of health economics capacity develop-
ment activities as part of the Research for Health in
Conflict in the Middle East and North Africa
(R4HC) project. The R4HC project aims to strengthen
capacity for health research in the Middle East and
North Africa region, with a focus on health, political
economy of health, and complex non-communicable dis-
eases and facilitate more effective translation of research
into policy. The project has seven core partners – Hacet-
tepe University in Turkey, American University of Beirut
in Lebanon, King Hussein Cancer Center in Jordan, Bir-
zeit University in West Bank, OPT and three United
Kingdom partners (King’s College London, Imperial Col-
lege London and Cambridge University).
The focus of this particular needs assessment is two-
fold – (1) to describe, based on a bibliometric analysis,
the recent corpus of health economics research pub-
lished by authors in Jordan, Lebanon, OPT and Turkey
in terms of volume, thematic areas, and collaboration
patterns, and (2) to identify, using an online survey, the
health economics areas that researchers and practi-
tioners see as most important to develop as well as their
preferred learning styles for health economics topics.
Methods
Our approach combined a bibliometric analysis of health
economics research outputs produced in the four target
jurisdictions with an online survey of academic and non-
academic health professionals. The bibliometric analysis
was conducted first in order to provide an initial over-
view of health economics activity in terms of topics and
active organisations; its main findings then informed the
design and dissemination of the online survey.
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Bibliometric analysis
The bibliometric analysis focused on the question –
‘What type of health economics research has been pro-
duced in Jordan, Lebanon, OPT and Turkey between 1
January 2014 and 31 December 2018?’ There were two
specific questions:
 Which health economics topics have been
researched by organisations in the four jurisdictions,
and to what extent?
 Which organisations have published health
economics research and what are their co-
publishing patterns, both within and outside the
Middle East and North Africa region?
Data sources
Seven electronic databases were searched on 28 January
2019 – two databases with an economic focus (Econlit–
Ovid and NHSEED), three health-focused databases
(MEDLINE, including MEDLINE In-Process, EMBASE
Classic and Embase, and Global Health – all searched
through Ovid), two generalist databases (Scopus and
Web of Science) and one regional database (Index Medi-
cus for the Eastern Mediterranean Region).
Search strategy
A custom literature search strategy was devised with the
help of an information specialist at Imperial College
London Medical School Library. The search strategy
comprised two types of search terms – geographic de-
scriptors (i.e. the names of the four jurisdictions
searched in the ‘institution’ field of each database) and
subject descriptors (i.e. keywords pertaining to health
economics). We tested four search strategies for health
economics research outputs, informed by previous
bibliometric reviews [13, 14, 15] and reference textbooks
(details in Additional file 1), and selected a search strat-
egy that was then adapted and ran across seven data-
bases (full search strategies in Additional file 1).
Eligibility criteria
The following inclusion criteria were applied: scope – ti-
tles or abstracts that explicitly listed any economic out-
come related to health, disease or disability, including but
not limited to cost, cost-effectiveness, patient-reported
outcomes, health expenditure, provider or health system
performance, and poverty associated with accessing
healthcare; geography – studies with at least one author
affiliated with an organisation in Jordan, Lebanon, OPT
(West Bank and Gaza) or Turkey; language – studies in
any languages; publication date – studies published be-
tween 1 January 2014 and 31 December 2018; publication
type – studies published as journal articles (original
articles and reviews), book chapters, conference proceed-
ings and theses. Editorials were excluded.
Study selection
Search results from each database were downloaded in
Microsoft Excel and duplicates were removed. The follow-
ing fields were retained for each record: title, abstract, au-
thors, authors’ affiliations, publication year and publication
journal/source. Titles and abstracts were screened by the
lead researcher (AG). Institutional affiliation data were
cleaned manually for the records meeting the inclusion cri-
teria. For the authors’ institutional affiliation, only the
highest-level affiliation was retained (e.g. Department of In-
ternal Medicine, Faculty of Medicine, University of Buenos
Aires was recorded as University of Buenos Aires).
Data analysis
Descriptive analyses were conducted in Microsoft Excel
and bibliometric analyses were conducted using VOS-
viewer software version 1.6.10 [16]. Two types of analyses
were conducted using VOSviewer functionalities – key-
word co-occurrence and co-publication networks. Key-
word co-occurrence was analysed based on VOSviewer’s
built-in natural language processing algorithms, which
were applied to the titles and abstracts of included records
[17]. The software allows a similar analysis of author and
database-indexed keywords, but a deliberate decision was
made to conduct the analysis only on titles and abstracts
to ensure that the body of text was as uniform as possible
across sub-disciplines, journals and indexing databases as
well as to minimise any systematic differences in the au-
thors’ choice of keywords. The binary counting method
was used to assess the frequency of terms, whereby a given
word (sequence) is counted only once per record irre-
spective of how many times it appears within it.
For co-publication networks, both organisations and
jurisdictions were analysed based on the authors’ affilia-
tions. When there were more authors from a single or-
ganisation, the organisation was counted only once. The
fractional counting method was used to ascertain coun-
try and organisation authorship, whereby the strength of
a co-authorship link between two organisations is deter-
mined not only by the number of records co-authored
but also by the total number of organisations of each of
record – this method reduces the influence of large col-
laborations. For example, if a study is authored by au-
thors from five different organisations, each link
between two co-authoring organisations gets a strength
of 1/5 (versus a strength of 1 if the full counting method
had been employed) [18].
Results are presented as network visualisations, where
each circle depicts a keyword (or institution); the size of
the circle is proportional with the number of records
mentioning that keyword (or authored by someone at
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that institution). The closer two keywords (institutions)
appear and the thicker the links between them and the
larger the number of records in which they appear (co-
author) together. The colours distinguish between clus-
ters of keywords (institutions), i.e. collections of
keywords (institutions) that tend to appear (publish) to-
gether. A keyword (institution) can only belong to one
cluster.
Online survey
The survey focused on the following question: ‘What are
the capacity development priorities for health economics
among academic and non-academic professionals in
Jordan, Lebanon, OPT and Turkey?’ There were three
specific questions:
 Which health economics topics have respondents
received training in and applied in research or
analysis, respectively, over the past 5 years?
 Which health economics topics are respondents
most interested to develop in the future?
 What are the respondents’ preferred modalities to
develop their health economics skills and
knowledge?
Survey sample
Survey respondents were identified through several
means. Firstly, the email addresses of the authors of the
566 records included in the bibliometric analysis were
identified based on information publicly available online
on their respective institutions’ and departments’ websites.
Secondly, R4HC project partners were consulted on the
relevant academic and non-academic institutions/depart-
ments to approach in each country. Thirdly, representa-
tives of relevant regional organisations (e.g. WHO Office
for the Eastern Mediterranean Region) and in-country
professional associations (e.g. local chapters of the Inter-
national Society for Pharmacoeconomics and Outcomes
Research (ISPOR)) were approached for additional rele-
vant professionals/organisations and for support with dis-
seminating the questionnaire within their networks. A
consolidated list of potential respondents was created by
combining these three sources. Only researchers affiliated
with university departments of public health, pharmacy,
health economics, health policy and economics were
retained as these departments were judged to be likely
hosts of institutional health economics expertise.
Recruitment
Individuals on the consolidated recruitment list were sent
an email invitation to participate in the survey; the recruit-
ment email explained the purpose of the study and invited
recipients to participate by clicking the enclosed weblink,
which lead to the online questionnaire. The recruitment
email also encouraged recipients to forward the recruitment
email to colleagues for whom health economics is a discip-
line relevant to their professional role. A total of 286 unique
individuals across the four target jurisdictions and the re-
gion were sent the invitation email from 9 September 2019.
A single reminder email was sent to all recipients around
20 September 2019.
Survey instrument
The survey instrument (Additional file 1) distinguished
between two tracks based on the respondents’ profes-
sional role, as reported in the first question. The tech-
nical track applied to respondents self-identifying as
academic researchers, technical analysts (non-academic)
and clinicians); the 14 questions focused on detailed
health economics methods. The managerial track ap-
plied to respondents self-identifying as policy managers
or healthcare administrators; the 12 questions focused
on the application of health economics methods to an-
swer higher-level policy questions. In questions about
past exposure to health economics topics, respondents
were presented with multiple choice items, e.g. ‘no ex-
posure to the topic’, ‘I have worked on this topic’ or ‘I
am an expert in this topic’. In questions concerned with
future priorities in terms of health economics capacity
development, respondents were asked to rank the items
(using the drag and drop functionality of the survey plat-
form) from the most important to the least important.
This approach was preferred to the Likert-scale rating
approach used by the WHO Hennessy-Hicks needs as-
sessment tool [19], which compares, for a given skill, the
self-reported achievement and the perceived importance
of the skill for the professional role, for two reasons,
namely health economics is a niche discipline in the
public health space and preliminary discussions with
R4HC consortium partners and other academics in
Jordan, Lebanon and Palestine indicated that there were
very few ‘pure’ health economists in these settings. As
such, a deliberate decision was made to broaden the pro-
fessional profiles of the response sample while acknow-
ledging that their professional role specifications (where
these are available) may not include explicit health eco-
nomics competencies.
The draft survey (English version) was piloted with five
researchers (including two health economists) in the
Global Health Development group at Imperial College
London and five health systems researchers with re-
gional experience (including four health economists),
following which modifications were made based on their
feedback. The English version was then translated into
Arabic and Turkish by native speaker health economists.
Based on the pilot we anticipated that completing the
survey would take between 10 and 15minutes; this in-
formation was included in the participant information
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sheet linked to the recruitment email ‘[the survey]
should take about 10–12 minutes to complete’. No in-
centives were offered to respondents for completing the
survey.
Data collection
Survey responses were collected using the Qualtrics
platform through the Principal Investigator’s Imperial
College’s secure account. The online questionnaire was
open for a period of 5 weeks (9 September to 14
October 2019), following which it was locked and re-
sponses were no longer accepted. Each page of the on-
line questionnaire allowed responses to be collected in
English, Turkish or Arabic based on the translated ver-
sions, as explained above.
Data analysis
Survey responses were downloaded in spreadsheet for-
mat for cleaning, following which they were transferred
to R statistical software for analysis [20]. Partial re-
sponses were kept on the Qualtrics platform, but not
downloaded for analysis. Responses to each question
were summarised using appropriate descriptive statistics
(e.g. proportions) and by subgroups (e.g. by country, by
type of institution).
Results
Summary of studies included in the bibliometric analysis
The literature search identified 15,185 records across all
databases, of which 8401 were unique records whose ti-
tles and abstracts were screened against the inclusion
criteria (Fig. 1). Of the 1566 records with a central
health economics topic, 566 had at least one author
from an institution in either Jordan, Lebanon, OPT or
Turkey; these 566 articles were retained for the biblio-
metric analysis.
Most included records were journal articles (n = 461,
81%); there were also 102 conference proceedings (18%,
most of them at ISPOR European or ISPOR World con-
gresses) and 3 books/book chapters (Table 1). About half
had authors from one or two distinct organisations, but
there were also large collaborations between five or
more organisations (n = 121, 21%). Of the collaborations
between two or more organisations, half were inter-
national collaborations and half were collaborations
among domestic organisations only.
Most records had at least one author from a Turkish
organisation (n = 464, 82%), followed by Lebanon (n =
53), Jordan (n = 38) and OPT (n = 15). Only 7 records
(1% of total) were the product of collaborations between
authors in at least two of the four jurisdictions: Jordan–
Lebanon (2), Jordan–Turkey (1) and Turkey–OPT (4);
there was no record with authors in three or all four ju-
risdictions. Most records had authors affiliated with an
academic organisation (n = 506, 89%), but there was also
authorship from service providers (e.g. teaching hospi-
tals) and healthcare industry organisations (29% and
22%, respectively).
Value in Health was by far the most common source
of journal articles (n = 70, 15%), with the other top ten
journals by number of records representing a combin-
ation of international (e.g. The Lancet, International
Fig. 1 Study inclusion flowchart
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Table 1 Summary of studies included in the bibliometric analysis (n = 566)
Characteristic N %
Publication year
2014 101 17.8
2015 117 20.7
2016 121 21.4
2017 111 19.6
2018 116 20.5
Total 566 100.0
At least one author from an organisation in
Jordan 38 6.7
Lebanon 53 9.4
Occupied Palestinian Territories 14 2.5
Turkey 464 82.0
Any two of the above 7 1.2
Any three from the above 0 0
Number of distinct organisations per record
One 160 28.3
Two 133 23.5
Three 96 17.0
Four 56 9.9
Five or more 121 21.4
Total 566 100.0
Of collaborations between at least two organisations
International collaborations 201 49.5
Domestic-only collaborations 205 50.5
Subtotal 406 100.0
Publication type
Journal article 461 81.4
Conference proceeding 102 18.0
Book or book chapter 3 0.5
Total 566 100.0
Type of organisation
Academic (e.g. university, research institute) 506 89.4%
Service provider (e.g. teaching hospital) 162 28.6%
Public administration (e.g. Ministry of Health) 53 9.4%
Industry (e.g. pharma company, consultancy) 129 22.8%
Other (e.g. Non-governmental organisation, international organisation) 11 1.9%
Top journals (by number of articles)
Value in Health 70 15.1
PLoS One 7 1.5
International Journal of Health Planning and Management, Value in Health Regional Issues 6 1.3
The Lancet, Turkish Journal of Medical Sciences, Tuberkulos ve Toraks 5 1.1
Gheorghe et al. Health Research Policy and Systems           (2020) 18:99 Page 6 of 13
Journal of Health Policy and Management) and national
journals (e.g. Turkish Journal of Medical Sciences, Jordan
Journal of Pharmaceutical Sciences). Further disaggrega-
tions by country in terms of collaboration patterns and
research productivity are presented in Additional file 1.
Bibliometric analysis – health economics topics
Three health economics topics are apparent across the
included records, namely cost analysis, cost-effectiveness
analysis and health system economics (Fig. 2). Cost ana-
lysis (green cluster) is illustrated by terms like ‘total
cost’, ‘hospitalisation’, ‘economic burden’ and ‘annual
cost’. This area is closely linked to cost-effectiveness
analysis (blue cluster), which contains terms like ‘cost-ef-
fectiveness’, ‘sensitivity analysis’ and ‘life year’. Health
system economics (red cluster) is the richest category
and includes a large and varied body of terms, e.g. ‘coun-
try’, ‘system’, ‘efficiency’, ‘analysis’, ‘implementation’, ‘ac-
cess’ and ‘income’.
Further results of the text analysis, by type of publica-
tion (conference proceedings versus journal articles) and
by jurisdiction, are provided in Additional file 1. From a
disease burden perspective, no topics immediately stood
out. However, most keywords pointed towards chronic
conditions, particularly in Lebanon (e.g. ‘tobacco’, ‘can-
cer’, ‘stroke’). From a service delivery perspective, ‘phar-
maceuticals’ and ‘hospital care’ were invoked the most
frequently.
Bibliometric analysis – co-publication patterns
Turkish organisations co-published across a network
of 55 different countries, while OPT and Lebanon
had fewer links (36 and 30 different countries, re-
spectively) and Jordanian organisations had links only
to 15 countries (Additional file 1, Fig. A1.1). Notably,
Turkey, Lebanon and OPT appear so close to each
other in the visualisation not because authors from
these jurisdictions publish together, but because they
tend to publish with authors in the same third-party
countries – most prominently United States and, for
Turkey and Lebanon, also countries like Canada and
France.
Online survey respondents’ profile
Of 286 email invitations sent, 161 individuals opened
the survey and 83 responded to all questions (51.6%
completion rate). Three complete responses were re-
moved as the respondents now worked outside the
four target jurisdictions (in France, Switzerland and
United Arab Emirates), leaving 80 complete responses
in the analysis. The characteristics of the 80 respon-
dents are summarised in Table 2. The majority of re-
spondents self-identified as academic researchers and
had completed a doctoral degree, yet had varying
levels of experience as reflected by the time since
highest educational attainment.
Fig. 2 Text co-occurrence patterns in titles and abstracts, all included records (n = 566). Notes: only countries appearing in at least 5 records are
displayed; minimum 10 topics per cluster
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Online survey – health economics topics
The proportions of respondents reporting no previous ex-
posure to the listed health economics topics were between
35% and 65%, depending on the topic (Table 3). ‘Eco-
nomic evaluation’ and ‘measuring health utilities and
health-related quality of life’ were the topics that most re-
spondents reported to be familiar with but, even for these,
less than 40% of respondents reported to have worked on
them directly. At the other end of the spectrum, the least
previous exposure across the sample (about 15% of re-
spondents) was reported for ‘political economy analysis’,
‘measuring health equity’ and ‘measuring the efficiency of
health systems or providers’. Respondents who provided
free text details on their practical experience mentioned
the difficulty of obtaining cost-specific data and navigating
bureaucracy as main challenges of applying these methods
in their context.
‘Measuring the economic burden of disease’, ‘eco-
nomic evaluation’, ‘measuring utilities and health-related
quality of life’ and ‘measuring health equity’ were, on
average, the topics that respondents reported as most
important for them to develop in the future, while
‘measuring preferences’, ‘political economy analysis’ and
‘quasi-experimental methods’ were, on average, the least
important for their future professional development. Re-
sults were consistent across countries and types of
Table 2 Summary of survey respondents’ profile (n = 83)
Question N
Which country do you work in?
France 1
Jordan 16
Lebanon 13
Occupied Palestinian Territories 33
Switzerland 1
Turkey 18
United Arab Emirates 1
Which of the following best describes your current professional role?
Academic research 56
Clinical activity, for example, as a practicing physician or pharmacist 9
Healthcare management, for example, as a hospital administrator 4
Policy management, for example, as a head of unit in a government agency 3
Technical expert (non-academic), for example, as a health financing specialist 2
Other 9
Highest educational attainment
Doctorate (for example, PhD, DrPH) 50
Master (for example, MA, MSc, MPH) 23
Undergraduate degree (for example, Medicine, Dentistry, Economics) 7
Other 3
Years since highest educational attainment
Less than 5 years 38
Between 5 years and 10 years 16
More than 10 years 29
Type of employer
Government agency 6
Healthcare provider, for example, a hospital 9
International organisation 2
Non-governmental organisation 4
Private sector, for example, consultancy or pharmaceutical industry 4
University or research institute 54
Other 4
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professional roles, with only minor differences among
them, e.g. ‘measuring the efficiency of health systems
and providers’ was among top five topics in Lebanon but
not in the other three jurisdictions (Additional file 1).
Survey respondents on the managerial track (n = 7)
ranked ‘tools for navigating the politics of health sector
reform’ as their top professional development priority,
ahead of more technical topics like ‘costing health bene-
fit packages’.
Online survey – capacity development modalities
Respondents ranked short courses (2–5 days), learn-by-
doing and mentoring from an experienced professional
highest in terms of preferred learning styles for the
health economics topics they perceived as most import-
ant for their future professional development (Table 4).
As with health economics topics for future development,
preferences were generally consistent across countries
and types of professional roles, also with few differences,
e.g. stronger preference for online courses with a certifi-
cate of completion in Lebanon versus the other three
jurisdictions.
Discussion
Summary of findings
The bibliometric analysis found that recent health eco-
nomics research in Jordan, Lebanon, OPT and Turkey
appears concentrated on a limited number of themes,
namely cost analysis and cost-effectiveness analysis.
There appears to be a shared thematic focus across the
four jurisdictions on pharmaceuticals, hospital care and
chronic disease. Only 1% (n = 7) of the included research
outputs were the product of cross-jurisdiction
Table 3 Previous exposure to and importance of future development in health economics topics among survey respondents (n =
73)
Health economics topic Previous exposure - # respondents (%) Importance of future
development
I am an
expert on
this topic
I completed a face-
to-face course on this
topic
I completed an
online course on
this topic
I have
worked on
this topic
No
exposure to
this topic
Average
rank (SD,
IQR)
# respondents
ranking the topic in
top 3 (%)
Measuring the economic
burden of disease
9 (12.3%) 14 (19.2%) 4 (5.5%) 20 (27.4%) 33 (45.2%) 4.56 (2.67,
3-6)
32 (43.8%)
Economic evaluation 10 (13.7%) 14 (19.2%) 5 (6.8%) 28 (38.4%) 28 (38.4%) 4.68 (3.06,
2-7)
35 (47.9%)
Measuring health equity 5 (6.8%) 14 (19.2%) 1 (1.4%) 12 (16.4%) 48 (65.8%) 4.96 (2.76,
3-7)
25 (34.2%)
Measuring health utilities
and HRQoL
10 (13.7%) 14 (19.2%) 4 (5.5%) 30 (41.1%) 26 (35.6%) 5.18 (2.99,
3-8)
25 (34.2%)
Measuring the efficiency
of health systems or
providers
6 (8.2%) 11 (15.1%) 3 (4.1%) 10 (13.7%) 47 (64.4%) 5.27 (2.83,
3-7)
24 (32.9%)
Measuring healthcare
costs
8 (11.0%) 14 (19.2%) 2 (2.7%) 23 (31.5%) 35 (47.9%) 5.33 (2.53,
4-7)
18 (24.7%)
Formal policy analysis 3 (4.1%) 10 (13.7%) 1 (1.4%) 16 (21.9%) 44 (60.3%) 5.96 (2.72,
4-8)
16 (21.9%)
Measuring preferences of
health workers or
patients
8 (11.0%) 10 (13.7%) 2 (2.7%) 16 (21.9%) 41 (56.2%) 6.05 (2.70,
4-8)
17 (23.3%)
Political economy
analysis
3 (4.1%) 9 (12.3%) 2 (2.7%) 15 (20.5%) 48 (65.8%) 6.71 (3.4,
4-10)
17 (23.3%)
Quasi-experimental
methods
8 (11.0%) 12 (16.4%) 2 (2.7%) 14 (19.2%) 40 (54.8%) 7.15 (3.0,
5-10)
10 (13.7%)
Other - - - - - 10.14 (1.7,
10-11)
0 (0%)
For “Previous exposure” the survey question was “Thinking about the past 5 years (since September 2014), choose the statements that apply to you for each of
the following topics. Choose all statements that apply. For the purpose of this question, the following are NOT sufficient to be considered a 'course': one-day
activities; individual study without an instructor; attending one-off lectures, conference presentations, seminars, webinars.”; line totals do not add up to 100%
because respondents could choose more than one response item under each health economics topic
For “Importance of future development” the survey question was “Which of the following health economics topics do you consider most important for you to
develop in the future?
Order (drag and drop) the following options from the most important (1) to the least important (11).” Results exclude three respondents outside the four focal
jurisdictions and seven respondents with policy or management roles
Abbreviations: HRQoL health-related quality of life, IQR interquartile range, SD standard deviation
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collaborations between researchers in at least two of the
four jurisdictions included in this study.
Economic evaluation and economic burden of disease
were ranked, on average, highest in terms of importance
for future development. Short courses, learning by doing
and mentoring from an experienced professional were,
on average, the learning styles ranked highest by way of
preference for developing these topics. Findings were
generally consistent across countries and types of profes-
sional role.
Interpretation of findings
The combined findings of the bibliometric analysis and the
online survey indicate that some health economics research
capacity appears to be in place in the focal jurisdictions,
particularly for economic evaluation, measuring health util-
ities and healthcare costs. The focus of research outputs on
pharmaceutical technologies, the dominance of conference
presentations (predominantly ISPOR) and of Value in
Health as the target journal (particularly for Turkish au-
thors), combined with the still nascent processes for incorp-
orating economic evidence into government healthcare
planning and decision-making (particularly in Jordan,
Lebanon and OPT), suggest that the pharmaceutical indus-
try may have had an important role in shaping the focus of
existing health economics capacity in the region.
By contrast, there has been much less recent research
and exposure to methods relating to the analysis of
healthcare markets (e.g. competition, insurance, provider
and patient behaviour), equity (in health outcomes, ac-
cess to health services or health financing), or the deter-
minants of provider performance. These three topics are
particularly under-represented in research from organi-
sations in Lebanon and Jordan.
The differences among the four target jurisdictions
may well explain some of these thematic variations.
Turkey stands out in terms of the volume and thematic
breadth of research outputs, potentially signalling a
stronger, more mature health economics research base –
a finding aligned with the size of its economy and of its
higher education sector as well as more than a decade of
structural health sector reforms [21]. On the other hand,
the constraints related to financing, information systems,
governance and security, among others, inherent to
health sectors in Jordan, Lebanon and OPT have been
comparatively more severe over the same time interval
and it is conceivable that the opportunities for health
economics research and capacity-building have been
correspondingly fewer and less diverse.
Our results must be interpreted with caution. Firstly, ana-
lysing research outputs and individual professionals’ views
of capacity development does not tell the whole story of re-
search capacity. The existence of health economics research
outputs is not necessarily equivalent to capacity being in
place and the absence of research outputs does not neces-
sarily mean that research is not being conducted or that re-
search capacity has never been in place. For example,
researchers at Birzeit University published original research
on health equity in 2008–2009 [22, 23] but this individual
capacity is no longer in place at Birzeit University.
Secondly, some thematic areas (e.g. economic evalu-
ation) being prioritised more highly by survey respon-
dents in terms of their future professional development
relative to others (e.g. provider performance analysis,
political economy analysis) does not necessarily mean
that the latter topics are perceived as less valuable, ne-
cessary or important in a given context. It may well be
the case that weak policy demand for certain types of
analyses, lack of career progression opportunities or the
structure of existing public health/health systems/health
economics training are prominent considerations shap-
ing the responses.
The low share of cross-jurisdiction collaborations in
health economics research (n = 7 of 566 records) is strik-
ing. Turkish–Arabic language barriers are unlikely to be
significant as five of the seven collaborative pieces
Table 4 Preferred learning style for health economics topics among survey respondents (n = 80)
Average rank (SD,
IQR)
Number of respondents ranking the option in top 3
(%)
Face-to-face course (2–5 days) 2.80 (2.06, 1–4) 58 (72.5%)
Direct mentoring from an experienced professional 3.61 (1.74, 2–5) 43 (53.8%)
Learn by doing 3.67 (2.20, 2–5.25) 43 (53.8%)
Master-level course in academic institution 4.47 (2.18, 3.6) 27 (33.8%)
Peer-to-peer learning 4.51 (1.81, 3–6) 25 (31.3%)
Online course with graded assessment(s) and certificate of
completion
4.68 (1.91, 4–6) 19 (23.8%)
Online course without graded assessment(s) 5.21 (1.95, 3.75–7) 20 (25%)
Other 7.02 (1.88, 7–8) 5 (6.3%)
The survey question was ‘For the top 3 [health economics] topics you ranked above, what would be your preferred learning style? Order (drag and drop) the
following options from the most preferred (1) to the least preferred (8)’. Excludes three respondents outside the four focal jurisdictions
IQR interquartile range, SD standard deviation
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included a Turkish institution – also despite the share of
entirely domestic collaborative publications being the
highest in Turkey among the four jurisdictions. The
availability and accessibility of regional funding pools for
health research requires further attention as it is likely to
stimulate long-term cross-jurisdiction collaborations and
multiply opportunities for capacity development. The
progress made to this effect in Latin America can offer
potentially useful insights [24].
Strengths and limitations
To our knowledge, this is the first systematic exploration
of capacity for health economics research in the Eastern
Mediterranean region that goes beyond economic evalu-
ation. The combination of a comprehensive literature
search, bibliometric analysis and online survey generated
consistent and complementary results.
There are also limitations. We captured capacity primarily
among knowledge producers (i.e. academics and technical an-
alysts), which are only one category of stakeholders in the
healthcare priority-setting landscape for a given context [25].
Furthermore, we focused on individual-level capacity and not
on organisational or institutional levels in the absence of estab-
lished health economics academic departments in these juris-
dictions. In the bibliometric analysis, ascertaining whether an
article had a central health economics topic based on single-
screening the title and abstract entailed a degree of subjectiv-
ity, for example, it was particularly difficult to adjudicate
articles about ‘access to health services’ as it was difficult to
distinguish between health services research and health equity
as the central topic. Assessing the methodological quality of
the health economic literature was left outside the scope of
the analysis given the expected large number of records and
the broad conceptual scope – quality criteria are available for
various types of economic analysis, such as economic evalu-
ation [26] and using data envelopment analysis to measure
the performance of service providers [27], but these would be
difficult to reconcile across study types.
The survey sample was not statistically representative,
the response rate was at most 30% (most likely lower
given the snowball dissemination of the recruitment
email) and the number of responses per country was of
around 20 – as such, results can offer only an indication
of the true picture. However, the completion rate of 50%
was in line with acceptable ranges for unsolicited online
surveys. Furthermore, no exhaustive definitions of re-
sponse items were provided (e.g. health equity analysis,
political economy analysis); therefore, it is possible that
responses over- or under-estimate the exposure or per-
ceived importance for future development if respondents
did not fully recognise the terms. The low response rate
among policy-makers and health administrators pre-
cludes any meaningful conclusion for this category of
respondents.
Only 21 abstracts (4% of total) included at least one of
the terms ‘refugee’, ‘conflict’ or ‘Syria’ – somehow sur-
prising given the protracted tensions in OPT and the
proximity of the Syrian conflict (started early 2012) dur-
ing the time scope of this review. Given our inclusion
criteria stipulating at least one author to be affiliated
with an institution in the four jurisdictions, we may have
missed outputs from international organisations focusing
on this topic. At the same time, it is also possible that
health economics research conducted by domestic au-
thors tends to focus rather on resident populations than
on displaced populations, in line with the local concep-
tualisation of what UHC means; however, a more com-
prehensive and targeted analysis would be better placed
to ascertain whether this is actually the case.
Implications for capacity development
Using these findings to inform capacity development ac-
tivities with a health economics focus requires attention
from the outset to the various levels at which capacity
needs developing in a given context, the types of cap-
acity to be built at each level and, above all, the import-
ance of being clear about the purpose for capacity
development in the first place as these will determine
the necessary activities. For instance, there are indica-
tions of health research waste in Palestine [28] in the ab-
sence of research priority-setting mechanisms [29]; in
this case, developing technical expertise can only bring
limited results if investment is not directed also towards
overcoming barriers to making research more relevant
for policy-making, particularly as there is evidence of lit-
tle engagement in knowledge translation activities from
health research institutions in the region [30]. The influ-
ence of conflict adds another dimension relevant to the
region as a whole, as challenges to developing capacity
are more taxing compared to ‘conventional’ settings and
corresponding capacity development activities require,
among others, focusing on organisations and functions
(rather than individuals), increasing trust within and
across research teams and research participants, and
considering novel ways to conduct and communicate re-
search results timely [31].
Our findings generate several working directions for a
capacity development plan. First, making the most of
already available health economics capacity appears both
necessary and possible. Two academic centres appear to be
at the centre of the co-publication networks in their re-
spective countries – Hacettepe University (Turkey) and the
American University of Beirut (Lebanon) – and they are
therefore immediate candidates for co-designing and co-
delivering capacity development activities to other national
partners. Second, capacity development activities that focus
on both knowledge transfer (e.g. short courses), practical
applications (e.g. learn by doing) and confidence building
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(e.g. mentoring) appear to respond best to the potential
beneficiaries’ expectations; an additional element of activ-
ities aimed at building trust and collaboration routines
across institutions (e.g. regional visiting fellowships) could
also energise cross-jurisdiction collaborations. Third, link-
ing together existing pockets of expertise within and across
countries appears sensible with a view to sustainability, for
example, by leveraging the existing EMRO-DCP Health
Economic Evaluation Network [32] and existing academic
concentrators of expertise toward establishing a regional
centre of excellence for health economics research. Fourth,
stimulating links between policy-makers and researchers re-
quires particular attention with a view to encouraging lo-
cally led research studies to be commissioned by decision-
makers seeking answers to pressing questions on the path
towards UHC – it is unlikely that health economics cap-
acity will be sustainably built in the absence of strong and
sustained policy demand for such evidence.
Conclusions
Future efforts to strengthen health economics capacity
can build on the existing available expertise as a starting
point for developing tailored programmes that take into
account the specificities of each jurisdiction, reflected, for
example, in preferences for learning styles and in the na-
ture of existing professional networks. Developing confi-
dence, trust and effective collaborations, both among
existing pockets of expertise and between researchers and
policy-makers, are potentially promising directions for the
design of future capacity development programmes.
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